Glenmark Will Pay $25M To End Feds' Price-Fixing Suit
By Travis Bland · September 4, 2024, 6:00 PM EDT
Glenmark Pharmaceuticals USA will pay $25 million to resolve allegations that it violated the False Claims Act by conspiring to fix the price of a generic high cholesterol drug, federal prosecutors...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login